REFERENCES
1. KEIL Julian, Saunders Donald E.. Urban
and rural difference in cardiovascular disease in black. 1991, 2: 17-27.
2. KORMITZER M., DRAMAIX M., KITTEL F., de BACKER
G.. Classe sociale et risque de cardiopathie ischémique. Rev.
prat . 1981; 31 (53) : 3805-3822.
3. BYERS T., MASHALL A.J.. Proceedings of
the Symposium on Nutrition in the Epidemiology and Prevention of Cardiovascular
Diseases, Diabetes Mellitus, and Obesity in Developing Countries, SCN's 22nd
Session, Pan American Health Organization. Washington, 12 Junes 1995, SCN News
No 13: 14-19.
4. JERVELL J.. Proceedings of the Symposium
on Nutrition in the Epidemiology and Prevention of Cardiovascular Diseases,
Diabetes Mellitus, and Obesity in Developing Countries, SCN's 22nd Session, Pan
American Health Organization. Introduction: Overview and Implications for the
Futures. S.N.C. News, 1999; 13: 10-14.
5. WORLD Hearth Organisation. Non
communicable diseases : A strategy for the african region . WHO Region al
office for African Harare 2000.
6. ESCALLIER R.. La croissance des
populations urbaines en Afrique. ESP POP SOC., 1998 ; 2 : 177 -182.
7. JERVELL J.. La survenue du diabète
type 2 (DNID) peut être prévenue? I.D.F bulletin, 42, 1997; 42:
1-3.
8. DESMOSIERES A., THEVENOT L. Les
catégories socio-professionnelles, collection repères: la
découverte. 1988: 128.
9. COLHOUN H..M., HEMINGWAY H., POULTERNE . R
.. Socio-economic status and blood pressure an overview analysis. J
Hum hypertens, 1998; 12 : 91-110.
10. MORGENSTER H.. The changing association
between status and coronaires heart diseases in rural population. Soc. Med.
1981; 14 A: 191-201.
11. MUGAMBI M..Migration, salt consumption
and blood pression in African population. Tropical cardiol, 1987; XIII(suppl):
167-169.
12. BERTRAND Ed.. Hypertension
artérielle des populations originaires d'Afrique noire. Ed. Pradel,
Paris 1995: 2-6.
13. MBUYAMBA KABANGU J.R., FAGARD R., STAESSEN J.,
LIEJENE N., MBUY wa Buy R.J.. Blood pression in Bantu of Zaïre:
epidemological aspects. Tropical Cardiol. 1987; XIII (suppl): 133-120.
14. KOFFI N. M, SALLY J, KOUAME P., DIARRA Nana
A.J.. Faciès de l'HTA en milieu professionnel à
Abidjan, Médecine d' Afrique noire, 2001; 48: 257-260.
15. MBALA M.. Obésité,
distribution des graisses, pression artérielle et prévalence de
L'HTA dans une population active. Mémoire de spécialisation,
Université de Kinshasa, 1996.
16. ABOA E.A. C. Facteurs de risque chez les
coronariens Noirs Africains : étude pilote cas témoins
réalisée en Côte-d'Ivoire. Msc Thesis, IMTA, ANTMERSPEN,
1996.
17. BERTRAND Ed., KACOU GM., MONKAM-M..
Maladie coronaire, sous développement et développement: Comment
le développement économique favorise-t-il les maladies
coronaires? Cardiol Tropical, 1984; 10 (n° spécial) : 51-64.
18. MBALA M., MBUYAMBA J.R., TAMBWE M.J., DIKASSA
L.N.. Pression artérielle initiale et pronostic de l'accident
vasculaire cérébral. Arch. Mal. Coeur ,1995; 88: 21-5.
19. LONGO MBENZA B., K. TONDUANGU, K. MUYENO, M.
PHANZU et al. Predictors of strocke associated mortality in
africans. Rev. Epidem. et Santé publique, 2000, 48, 31-39.
20. LIMBOLE E.. Prévalence des AV.C.
aux CUK, Mémoire de spécialisation, Université de
Kinshasa, 2001.
21. LONGO-MBENZA B., BAYEKULA M., NGIYULU R., KINTOKI
VE., NKIABUNGU F., BIKANGI, SESHERS KV., et al. Survy of
rhumatic heart disease in school children of Kinshasa town. Int J Cardiol
,1998; 63(3): 287-294.
22. MUNYCK A., EPRISTAT.. Institut de
Médecine tropicale Princes Léopard. Anvers, 1996-1997.
23. ELANDT-JOHNSON RC.. Définition of
rates: some remarcks on they use and misure. Am J Epidem., 1975; 102 : 267 -
271.
24. HILL A-B. The environment and
association or causation? Proc R Soc Med., 1965; 58: 295 -300.
25. KEYS A., MENOTTI A., ANAVAIRS, C. et
al. The seven countries study: 2289 deaths in 15 years . Prev.
Med. 1984; 13: 141-154.
26. DUCIMETERE P., RICHARD J.L., CLAUDE J.R et
al. Les cardiopathies ischémiques, Incidence et facteurs
de risque, l'étude prospective parisienne. Paris: Inserm, 1980.
27. ANDERSON K.M., CASTELLI W.P., LEVY D..
Cholesterol and mortality 30 years of follow-up Framigham study. JAMA 1987;
257: 2176-80.
28. RICHARD JL, BURCKERT E., DELA HAYE F. et
al. Taux de cholestérol sanguin et mortalité Arch.
Mal. 1992; 85(III): 11-20.
29. WILSON PWF, ABBOT R.D., CASTELLI WP..
High density lipoprotein cholesterol and mortality. The Framigham heart study,
Arterosclerosis, 1988; 8: 737-41.
30. BRUCKERT E., EMMERICH J., DELA HAYE F. et
al. Rôle des triglycérides dans les maladies
cardio-vasculaires. Arch. Mal Coeur 1992, 85 (111): 29-35.
31. MELICHAR F.. Plasma cholesterol and
phospholipids in various occupationnal groups. J atheroscl. Res, 1965; 5:
432-435.
32. LONGO-MBENZA B.. Diabète
sucré et maladie cardio-vasculaires. Cardiol Trop, 1995; 21 (82) :
37-44.
33. TICOLAT P., BERTRAND ED.et
al. Aspects épidémiologiques de la maladie
coronaire chez le Noir Africain : à propos de 103 cas. Résultats
de l'enquête multicentrique prospective Coronatric. Card Trop. 1991,
n° spécial, 1991, 17: 7-20.
34. PYORALA K., SAVOLAINE N.E, KAUKOLAS S.,
HAAPAKOSKI J.. Plasma insulin as coronary heart disease risk factors:
relation ship to other risk factors and predictive values during 91/2 year
follow-up of the helsinski policeman population. Acta Med scand (suppl), 1985;
710 : 38 - 82.
35. SCHOUL JM., ARMAND B. DOCIMETERE P., CHABDS D.,
BRAU J. et al. Comparison of risk factors in
vasospatic angina without significant fixed coronary Narrowing to significant
fixed coronary narrowing and no vasospastic angina. Am J cardiol, 1986; 57:
199-202.
36. KHOSLA T., LOWE C.R, Obesity and smoking
habitts by social class .Br J Prev Soc Med. 1972; 26: 249-256.
37. . GUIZE L., ILIOU .L.Le traitement de
facteurs de risque de l'athérosclérose coronaire. Arch. mal coeur
1992; 85: 1687-93.
38. SROLE L., FISCHER A.K.. The social
epidemiology of smoking behavior 1993 and 1970. The Midrown Manhatan study Soc
Sc Med, 1973; 7: 341-358.
39. MARMOT M.G., ROSE G., SHIPLEY M. and HAMILTON
P.J.S.. Employment grade and coronary heart disease in Britisch civil
servants. J. Epidem. commyly Health, 1978, 32: 244-249.
40. HOLME I, HELGELAND A., HJERMANN I., LUND-LARSEN
P.G, LEREN P.. Coronary risk factors and socio-economic status, the
Oslo study Lancet. 1976; ii, 1396-1398.
41. CHARLES D., BARABE P. et TALBI D..
Infarctus du myocarde en Algérie. Cardiol. Trop. 1982; 8:13-19.
42. Joint National commitee on detection, evaluation and
treatment of high blood pressure Arch Intern Med. 1988; 148: 1023-38.
43. BERTRAND ED., COULIBALY AO., TICOLAT R..
Statistiques 1988, 1989 et 1990 de l'Institut de Cardiologie d'Abidjan (I.C.A).
Cardiol trop. 1991; 17 (68): 151-155.
44. BEYET P. ET DUFRESNE A.. Les
déviations axiales gauches de Q.R.S au Zaïre. Cardiol Trop. 1979;
5: 165-175.
45. American Heart Association. Human in
preventive cardiology. Amer Heart Association, Dallas,
1994.
46. ASMAR R.. Risques cardio-vasculaires et
normes ambulatoires de la pression artérielle. Am Cardiol Ang. 1998,
47(2): 75-80 Etude clinique de l'hypertension
artérielle en milieu hospitalier à Kinshasa., Mémoire de
spécialisation, Université de Kinshasa, Fac de Méd.,
1983.
47. MBARAGA N.Etude clinique de l' hypertension
artérielle en milieu hospitalier à kinshasa.Mémoire de
spécialisation ,Université de Kinshasa,Fac de
Méd.1983.
48. Report et a WHO consultation. Part 1,
Diagnosis and classification of diabetes mellitus. World Heart Organisation.
Department of non communicable disease surveillance, Geneva 1999: 59.
49. World Health Organisation/International Society
of Hypertension. Pratice guidelines for primary caire physicians. J.
hypertens. 1999; 17: 151-8.
50. VAN GAAL L. . Obésité:
physiopathologie, risques et traitement. Endocrinologie IX 1/Nutrition 1:18-32
51. DUCIMETERE P., ESCHEVEGE E., PAPOZL et
al. Relation stup of plama insulin level to the incidence of
myocardial infarctus and coronary heart desease mortality in a midle aged
population. Diabetologia 1980; 19: 205-10.
52. WELBORN T., WEARNE K.. Coronary heart
desease incidence and cardiovascular mortality in Busselton with reference to
glucose and insuline concentrations. Diabètes Care 1979; 2: 154-60.
53. FREIDMAN M., THORESEN CE., GILL J.Y, et
al. Determination of type A behavior and its effect on cardiac
recurrences in post myocardial infarctus patients: Summary results of the
recurent coronary prevention project. Am Heart J., 1986; 112: 653-64.
54. BOFFETTA P., GARFINKEL L.. Alcohol
drinking and mortality among men errolled in an American cancer society
prospective study. Epidem. 1990; 1: 342-348.
55. KLATSKY Al., ARMOSTRONG MA., FRIEDMAN GO..
Risque of cardiovascular mortality in alcohol drunkers, ex-drinkers
and non drinkers. Am J Cardiol. 1990; 66:1237-1242.
56. Qualité de la vie dans les affections
cardio-vasculaires en pratique quotidienne, Information médicale et
pharmaceutique 1987. CIBA-GEIGY S.A. Bâle Suisse. Ed. F.B. Buirdwood.
57. ROSEMAN R.H., FRIEDMAN M., STRAUS R., JENKINS
C.D., ZYZANSKI S.J., WURNM. Coronary heart disease in the western
collaborative group study: a follow-up experience of 4,5 years J. Chron. Dis.
1970: 23; 173-190.
58. KANNEL W., WOLF P.A., MC GEC DL., DAW
B.. Blood pressure arterial rigidity and risks of stroke. The
Framigham study Jama 1981; 245: 1225-9.
59. KEYS A.. Seven countries. A multivariate
analysis of death and coronary heart disease Cambridge (Mass): Haward
University Press, 1980.
60. JACOTOT B., LASERIE M., ESLEVA O., BAUDET M.F.,
DACHET C., Corps gras alimentaires et prévention des maladies
vasculaires. Etude chez le sujet sain. Rev. Fr. Corps gras 1985; 32:11-7.
61. KEYS A. MENOTTI A., ARAVORIS C. et al.
The seven countries study 30 years of follow up from Framingham study.
JAMA 1987; 257: 2176-80.
62. SEEDAT YK.. Race, environnement alcool
pressure: the south African experience. J. Hypertens 1983; 1: 7-12.
63. ROSE G., STAMLER J.. The intersalt
study: Background, methods and main results. J. Hum Hypertens. 1980; 3:
283-288.
64. WADSWORTH. Calcium and vascular
reactivity in ageing and hypertension. J Hypertens. 1990, 8 (11): 975-983.
65. DOCHERTY. Cardiovascular responses in
ageing: a review. Pharmacol. Rev., 1990; 42: 104-124.
66. DUSTAN H. P.. Antihypertensive
treatment in blacks. Trop. Cardiol, 1987; 13 (suppl.): 45-49.
67. FLETCHER A., BULPITT C.. Epidemiology of
hypertension in the eldery. J Hum. Hypertens. 1994, 12 (suppl.6): S3-S5.
68. AKINGKUGBE O.. Hypertension researh in
Africa: past, present and future. Trop Cardiol 1987; 13 (suppl):
195-201.
69. IKEME A.C.. Hypertension studies in
developping countries. Clin Exp. Hypertens. 1989, ALL: 825-839.
70. DONNISON C.P.. Blood pressure in the
African native. Lancet. 1929; (i): 6-7.
71. POULLEN N.R., KHAW K.T., HOPWOOD B., MUGAMBI M.,
PEART W.S., ROSE G.. Blood pressure and associated factors in a Kenyan
community. Hypertens. 1984; 6 (6 part 1): 810-3.
72. MANN G.V., ROELS A.A., PRICE D.L., MERRIL J.M..
Cardiovascular disease in Pygmies. J .chronic Dis. 1962; 15:
341-71.
73. MBUYAMBA K.. Blood pressure and
hypertension in blacks. Ph .D. Thesis, KUL, Leuven, 1986.
74. ADIGUN S.A. , DAWODU F.R.. The effect
of age on blood pressure and urinary, plasma and intraerytrocytaire levels of
sodium and K in normotensive Nigeria. Card. Trop. 1992;
18(69).
75. WILLIAMS AW.. Blood pressure differences
in Kikufu and Samburu communities in Kenya. East Afr. Med. J. 1969; 46:
262-268.
76. World Health Organization. World Health
Statistics Annual, Geneva: World Health Organization, 1985.
77. COLLART F.. Insulino-résistance
et hypertension artérielle. Pathologie cardio-vasculaire XWII, 3,
Medisearch 1991, (50); 5-9.
78. KULBERTUS HE.. The hemiblocks. The years
experience 1980.
79. ELAINE N., MANE B.. Anatomie et
physiologie humaine, 4è éd. du Renouveau
pédagogique INC, 1999.
80. Société Nationale d'Electricité
SNEL-25 ans: 1970-1995. Production: SNEL-D.G division: Presse et Relations
publiques, Mondorama-Fumugali, 1995.
81. Société Nationale d'Electricité,
1970-2000. 30 ans Mondorama-Fumugali, 2000.
82. LONGO-MBENZA B. Maladies
cardio-vasculaires en République Démocratique du Congo,
Communication personnelle, unpublished data.
83. LEON A.S ., MYERS M.J, CONNETT J. For
the MRFIT Research group leisure time physical activity and the 16-years risks
of mortality from coronary heart disease and all causes in the multiple risk
factor Intervention Trial ( MRFIT ). Int. J. Sports Med 1997; 18 ( suppl. 3 ):
S208-S215.
84. ARAKAWA K.. Effect of exercice on
hypertension and associated complications. Hypertens Res. 1996; 19 (suppl. 1):
S87-S91.
85. KONO S., SHINCHI K., IKEDA M., YANAI F..
Lifestyles, glucose tolerance and blood pressure in male self-defense
officiales in northen Kyushu, Japan. J. Hum. Hypertens. 1992; 6: 101-105.
86. LONGO-MBENZA B.. Diabetes mellitus in
Preventive cardiology. Results from intervention studies, Ed. Boehringer
Mannheim Gmbh ,1982: 118-141.
87. HEYDEN S.. Diabetes mellitus in
Preventives cardiology. Results from intervention studies, Ed. Boehringer
Mannheim GmbH, 1982: 118-141.
88. CORRAO MA., GUIDON G.E., SHARMA N.,SHOKOOHI
D.F.. Tobacco control country profiles.American cancer
society,Atlanta,GA,2002:72-73.
89. LONGO- MBENZA B.. Influence du tabagisme
passif en famille congolaise, Tabagisme actif et maladies cardiovasculaires
à Kinshasa, RDC. In Press.
90. ZANETTI et al. Sonoking nebits,
exposure to passive smoking and attitudes to a non-smoking policy among
hospital staff (1998) 112, 57-62.
91. ZHUP B. et al., Cigarette
smoking among junior high-school student in Beijing, China, 1992,
21:854-861.
92. KOKKEVI A., COSTAS S.. The epidemiology
of licit and illicit substance use among high-school student in Greece.
American journal of public health 1991; 81: 48-52.
93. LAGRUE G. .Peut-on endiguer
l'épidémie tabagique? Revue du Praticien, 1995; 320: 4-5.
94. SLAMA K.. Tobacco control and
prevention. A guide for low incomes countries. Iuatlo news bulletin on Tobacco
and Health 1998; 5-9.
95. GEE D., GORDON D.. The results of the
Framingham study applied to four other US based epidemiologic studies of
cardiovascular disease ( section 31 ), in Kannel WB , Gordon T (eds ): The
Framingham study:An epidemiological Investigation of cardiovascular Disease
USDHEW publication 1976; N° (NIH): 76-1083.
96. LONGO-MBENZA B., SEGHERS K.V., LUKOKI-LUILA E.,
BIKANGI F.. Moderate alcohol intake decreases the risk of myocardiocal
infarction and stroke, but results in an increase of Risk of all mortality in
central africans. In Press.
97. POULTER N.R., KHAW K.T. ,HOPWOOD B., MUNGAMBI M.,
PEART W.S., ROSE G.. et al. The Kenyan Luo Migration study:
Observation on the initiation of rise in blood pressure. BMJ 1999; 300:
967-72.
98. POULTER NR, KHAWK T, SEVER PS. Higher
BP's of urban migrants from an African low BP population are not due to
selective migration. Am. J. Hypertens 1998; 1 (3 part 3): 1435-55.
99. ABRAHAMS D.G., ALELE C.O.. The systemic blood pressure in
a rural west African community. West Afr. Med. J 1970; 9: 45-58.
100. FROHLICH ED.. Hypertension. In: Pearson TA, Criqui MH,
Luepker RV, Oberman A, Winston M. Primer in Preventive Cardiology. American
Heart Association, Dallas, 1994:131-142.
101. M'BUYAMBA-K JR, LIJNEN P., FAGARD R., AMERY A..
Intraerythrocyte Na+ concentratrion in black families with and
without hypertension. Methods and Finding in Experimental and Clinical
Pharmacology, 1986; 8: 437-442.
102. DOBSON A.J., GIBBER R.W., LEEDER S.R., O'CONNELL D.L..
Occupationnal differences in Ischemic Heart Disease Mortality and risks Factors
in Australia. Am J Epidemiol 1985; 122: 283-290.
103. MARMOT MG. et al. Hearth inequalities among
British civil servants: the while all II Study. Lanver 1991; 337: 1387-1393.
104. COLHOUM H., PRESCOH-CLARKER P.. The Health survery for
England 1994-1996, HMSO, London.
105. STAMLER R. et al. Higher blood pressure in
adults with less education some explanation from INTERSALT. Hypertension 1992;
42: 406-410.
106. OPIT LJ., OLIVIER GR.. SALZBERG M.. Occupation and blood
pressure. Med J Aust 1984; 140 (13): 760-764.
107. LANG T.. Social, professional conditions and arterial
hypertension: an épidemiological study in Dakar, Senegal, J. Hypertens
1988; 6: 271-276.
108. SHAPER AG et al. British regional study:
cardiovascular risk factors in middle aged men in 24 tows. Br Med J 1981; 283:
179-186.
109. JAMES SA. et al. Socioeconomic status,
JohnHenryism and blood pressure in blacks adults. Am J Epidemiol 1992; 135:
59-71.
110. SIEGRIST J., BERHARDT R., FENG Z., SCHETTLER G..
Socioeconomie differences in cardiovascular risk factors in China. Int. J
Epidemiol 1990; 19: 905-910.
111. JACOBSEN B.K., THELLE D.S.. Risk factors for coronary
heart disease and level of education .Am. J. Epidemiol 1988; 127: 923-932.
112. HOEYMANS N., SMIT HA., VERKLEIJ H., KROMHOUT D..
Cardiovascular risk factors in relation to educational level in 36000 men and
women in the Netherlands. Euro Heart J. 1996; 17: 518-525.
113. BUNKER C. et al. Factors associated with
hypertension in Nigeria civil servants. Prev Med. 1992; 21: 710-722.
114. JOSHIPP., KATE SK., SHEGOKAR V.. Blood pressure trends
and life style risk factors in rural India. J Assoc. Physician India 1993; 41:
479-581.
115. LONGO-MBENZA B., MBUYAMBA K., NGIYILU R., LUKOKI E.,
VANGU N., KINTOKI E. BIKANGI F.. Protein-energy mal nutrition, sicio-economic
status, obesity and blood pressure in poor African school children and
adolescents. In Press.
116. SEEDAT YK., REDDY J.. The clinical pattern of
hypertension in the South African black population. A study of 1000 patients.
Afr J Med Sci 1976; 5: 1-7.
117. LANG T., Parrente P., Salem G., TAP D.. Social,
professionnal conditions and arterial hypertension: an epidemiological study in
Dakar, Senegal. J. Hypertens 1988; 6(4): 271-6.
118. SYME SL., OAKES TW., FRIEDMAN GD.. Social class and
racial differences in blood pressure. Am J Public Health 1979; 64: 619-20.
119. CRUZ-COKER R., ETCHEVERRY R., NAGEL R.. Influence of
migration on blood pressure of Easter Islanders. Lancet 1964; (I): 697-9.
120. WILLIAMS DR. et HOUSE JS.. Stress, social support,
control and coping: a social epidemiological view. In Vadura B., Kickbush I,
eds Health promotion research towards a new social epidemiology. Copenhagen:
World Health Organisation, 1991: 147-72.
121. KORNITZER M., KITTEL F.N., DE BACKER G. , DRAMAIX M.,
SOBOLSKI J., DEGRES: Work load and coronary heart disease. In Siegrist and MJ.
Halhubert Myocardial Infarction and psychosocial risk, Berlin, Hiedelberg, New
York, 1980, 18-40.
122. BAKER D.. Maternal and fetal orgins of coronary heart
desease .J Royal coll physicians of London 1994: 28: 544-551.
123. LONGO-MBENZA B., NGIYULU R., BAYEKULA M., KINTOKI E.,
BIKANGI N., SEGHERS KV. et al.. Low birth weigth and risk of
hypertension in African school children. J Cardiovascular Risk 1999; 6:
311-314.
124. REDDY KS., YUSUF S.. Emerging Epidemic of cardiovascular
disease in developping countries. Circulation. 1998; 97: 596-601.
125. BIELELI E., MOSWA JL., DITUM, KANDJINGU K., MULUMBA M..
Prévalence du diabète sucré au sein de la population de
Kinshasa. Congo Médical 2000; II(15): 1058-1061.
126. SHIRIKI K., KUMANYIKA. .Special issues regarding obesity
in minority populations. Am Inter Med. 1993; 117(7): 650-654.
127. WOODMAN R.. WHO-Launches initiative against obesity
Lancet 1996; 347: 751-758
128. DELPEUCH F., MAIRE B.. Obésité et
développement des pays du Sud. Med. Trop. 1997; 57: 380-388.
129. RIMM EB., STAMPFER MJ., CIOVANNUCI E., ASCHERIO A.,
SPIEGELMAN D., COLDITZ GA. et al. Body size and fat distribution as
predictors of coronary heart disease among middle-aged and older US men. Am J
Epidem 1995; 141: 1117-1127.
130. STERN MP., HAFFNER SM.. Body fat distribution and
hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Anteriosclerosis 1986; 6: 123-130.
131. STAMPFER MJ., SACKS FM., SALVINI S., WILLET WC.,
HENNEKENS CH.. A prospective study of cholesterol, apolipoproteins, and the
risk of myocardial infarction. N Engl J Med 1991; 325: 373 - 381.
132. LONGO-MBENZA B., LUKOKI L., PHANZU M. KINTOKI V.. Is
Hyperucemia a risk factor of Stroke and coronary heart disease among Africans?
Int J Cardiol 1999; 71 : 17-22.
133. MARMOT MG. et al. Health inequalities among
British civil Servants: the whitehall II Study. Lancet 1991; 337 :
1387-1393.
134. BAKER IA .et al. Haemostatic and other risk
factors for Ischaemic heart disease and social class: evidence from the
caerphilly and speedwel studies. Int Epidemiol 1988; 17: 759-765.
135. BUNKER CH. et al. Factors associated with
hypertension in Nigeria civil servants. Prev. Med 1992; 21: 710-722.
136. GILBERTS EC., ARNOLD MJ., GROBBEE DE.. Hypertension and
determinants of blood pressure with special reference to socio-economic status
in a rural South Indian community. J. Epidemiol Commun Health 1994; 48: 258 -
261.
137. ZABSONRE P., SEDOGO B., DYEMKOUMA F.X.. BERTRAND ED.
Obésité et maladies chroniques en Afrique Sub-Saharienne. Med
Afr. Noire. 2000; 47(1): 5-9.
138. ZABSONRE P., SEDOGO B., DYEMKOUMA F.X., BERTRAND ED..
Evaluation des paramétres anthropométriques à BODO -
DIOULASSO Med. Afr. Noire 1999; 46(12): 548-552.
139. SOW AM., NDIAYE MF. , FASSA NOH.. Les facteurs
étiologiques de l'obésité au Sénégal. Med
Afr. Noire.1986; 33(8/9): 595 - 604.
140. KAHN JP., RADEL C., RAUTURE P... Aspects psychologiques
et psychiatriques des obésités. Ed. Techniques.
Encyclopédie Méd. Chir (Paris, France) Endocrinologie, 10506 Med
Af Noire. 1999; 46(12): 548-553.
141. WADDEN TA., STUNKAR D. et al. Social and psychological
consequences of obesity, Ann. Inter Med. 1985; 103: 1062-1067.
142. POBEE J., LARBI EB., BELCHER DW., WURAPA FK., DODUSRA.
Blood pressure distribution in a rural Ghanaian population. Trans R soc Trop
Med Hyg. 1977; 71: 66-72.
143. NEEL JV.. The thrity genotype revisite d. In: Koberling
J, Tahersall RB, eds. The genetics of diabetes Mellitus-Seronosymposium n°
47, London, Academic Press, 1982.
144. BOURGOIGNIE J., SONNET J., DECHEF G.. Etude du
diabète sucré de bantou de la région de
Léopoldville Ann Soc Belge Med. Trop. 1962; 42: 261 - 294.
145. HERMAN WH., ALI MA., AUUBERT RE. et al.
Diabètes mellituus in Egypt: risk factors and prevalence Diabetic
Medecine 1995; 12: 1126 - 1131.
146. GILL G., MBANYA J.C., ALBERT G.. Diabetes in Africa
F.I.D 1997: 294.
147. KANDJINGU K; BIELELI E, BIDINGIJA M, TSHIANI K..
Etude clinique du diabète sucré à Kinshasa. Med Afr Noire
1985; 32 : 53 - 61.
148. JACKSON W.P.U.. Epidemiology of diabetes in South
Africa. Adv Metab Disord. 1978; 9: 111-146.
149. A Multicenter Study UK prospective diabetes Study III.
Prevalence of hypertensive and hypotensive therapy in patients with
newly-diagnosed diabetes hypertension. 1985; 7: 118.
150. MIRCEA GS, Etude de deux paramètres
électrocardiographiques (Fréquences cardiaques et axe
électrique) dans une population industrielle. Mémoire de Licence
spéciale en cardiologie Université Libre de Bruxelles 1979.
151. KOUASSI B., RENAMBOT J., PIQUEMAL M. et al.
Accidents vasculaires cérébraux en Côte d'Ivoire. CR
6è séminaire Institut Cardiologie Abidjan 1992.
Cardiol Trop 1992 (n° spécial I): 154.
152. MADHAVAN S., ALDERMAN LH.. Sex and race differences in
cardiovascular outcomes among treated hypertensive subjets. Am J Hypertens
1992; 5 (Suppl II): 97 A.
153. RENAMBOT J., BAUDIN L., BEDA B. et al.
Hypertension artérielle et coronaropathies chez l'Africain Noir. Etude
de 42 coronariens et 100 hypertendus. Coeur Med Int 1975; 14: 403-9.
154. BUCHANAN GR., KAMP CA., LEVY EN.. Racial differrences in
Ristocetin induced platelet aggregation .Br J Haemat. 1981, 49: 455-64.
155. BERTRAND E., CLOITRE B., TICOLAT R. et al.
Activité plaquettaire, fibrinolyse et facteurs d'environnement
comparés chez 50 Africains et 50 Européens. Rôle de la
consommation de poissons. Nouv Rev Fr Hematol. 1987; 29: 237-245.
156. DUPUY E., FLEMING AF., CAEN JP.. Platelet function,
factor III, fibrinogen and fibrinolysis in Nigerians and Europeans in relation
to atherom and thrombosis. J Clin Pathol. 1978; 31: 1094-101.
157. World Health Organization, World Health statistics
annual. Geneva: World Health Organization, 1995.
158. Surveillance of risk factors for non communicable
diseases. The who step wise approach. World health organization. Geneva 2001.
| 
